Subthalamic hGAD65 Gene Therapy and Striatum TH Gene Transfer in a Parkinson’s Disease Rat Model
The aim of the present study is to detect a combination method to utilize gene therapy for the treatment of Parkinson’s disease (PD). Here, a PD rat model is used for the in vivo gene therapy of a recombinant adeno-associated virus (AAV2) containing a human glutamic acid decarboxylase 65 (rAAV2-hGAD...
Saved in:
Main Authors: | Deyu Zheng, Xiaohua Jiang, Junpeng Zhao, Deyi Duan, Huanying Zhao, Qunyuan Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | Neural Plasticity |
Online Access: | http://dx.doi.org/10.1155/2013/263287 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Probable Anti-Glutamate Decarboxylase 65 (Gad65) Antibody-Associated Cerebellar Ataxia. Clinical Case Report and Literature Review
by: J. Valinčiūtė, et al.
Published: (2023-11-01) -
Differential HLA Association of GAD65 and IA2 Autoantibodies in North Indian Type 1 Diabetes Patients
by: Neihenuo Chuzho, et al.
Published: (2021-01-01) -
Dopamine Dysregulation Syndrome and Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson's Disease
by: Beatriz De la Casa-Fages, et al.
Published: (2011-01-01) -
Differential Effects of Dopaminergic Therapies on Dorsal and Ventral Striatum in Parkinson's Disease: Implications for Cognitive Function
by: Penny A. MacDonald, et al.
Published: (2011-01-01) -
Deep Brain Stimulation Frequency of the Subthalamic Nucleus Affects Phonemic and Action Fluency in Parkinson’s Disease
by: Valéria de Carvalho Fagundes, et al.
Published: (2016-01-01)